At Advanced Urology, we are pleased to offer our patients HIFU, one of the most innovative and least invasive treatment options for prostate conditions. HIFU stands for High Intensity Focused Ultrasound, and it is a modern technique used to treat prostate cancer and BPH with a reduced risk of side effects and a high rate of success. HIFU uses high intensity focused ultrasound waves to completely destroy the prostate. This, in turn, destroys the prostate cancer. If the cancer is found early enough, HIFU is almost always an effective treatment option.

Unprecedented Control

The treatment device used during a HIFU procedure also captures images of the prostate gland during the procedure. This gives the physician precise control over the delivery of the treatment. This is what protects the surrounding tissues from damage normally associated with prostate treatments. The incidence of common side effects, such as impotence and incontinence, is greatly reduced with this high level of control.

Short Treatment and Recovery Times

Prostate treatment with HIFU does not take long. Most treatments can be completed in less than three hours. General anesthesia is not needed for this outpatient procedure. Most patients are able to return to their normal lifestyles within a few days of treatment.

HIFU requires no hospital stay and few incisions. Because it is not a surgery, the risk of blood loss is lowered tremendously. Patients experience only mild pain from HIFU, compared to the tremendous amount of pain associated with prostate surgery.

Other Benefits of HIFU

Because HIFU involves no radiation, it can be used as a salvage treatment if other prostate cancer treatments have failed. It can also be repeated if needed. Since the procedure destroys the prostate gland completely, it usually eliminates the cancer in cases that are caught before the cancer spreads into the body. To find out more about HIFU or to see if you qualify for this treatment, contact Advanced Urology today for an initial consultation!

IMPORTANT INFORMATION: The Sonablate® 500 is not approved for use in the U.S. The Sonablate® 500 remains investigational in the U.S. and is being studied for the treatment of prostate cancer in clinical trials in the U.S. FDA has made no decision as to the safety or efficacy of the Sonablate® 500 for the treatment of prostate cancer. Currently, the device is approved for the treatment of prostate cancer in Canada and the Dominican Republic, authorized in Argentina, and available in the Bahamas and Mexico.

If the Sonablate® 500 is approved by the FDA for use in the U.S., there is no assurance that instructions for use or the specifications of the device will be the same as the device and treatment approved or authorized in other countries outside of the U.S.